首页> 外国专利> PRODUCTION OF INSULIN-FUSION PROTEIN USING GENETIC ENGINEERING

PRODUCTION OF INSULIN-FUSION PROTEIN USING GENETIC ENGINEERING

机译:利用基因工程技术生产胰岛素融合蛋白

摘要

The present invention relates to a method for increasing the stability and expression rate of proinsulin fusion proteins in producing human proinsulin fusion proteins using genetic engineering.;First, the human proinsulin gene was cloned into E. coli host by cDNA cloning method. The cloned human proinsulin gene was introduced into pUC8 with the Lac ribosomal binding site gene, (Thr) 6 encoding [pUC8- (Thr) 6- PI], and pYK10 from pUC8- (Thr) 6- PI and pEX2. An -9 expression vector was prepared.;The fusion protein expressed in Escherichia coli in which pYK10-9 Berger with a short prosulin sequence was introduced was stable in E. coli cells. Escherichia coli pop2136 transformed with pYK10-9 expression vector produced 249 mg / l of human proinsulin fusion protein in flask fermentation, and the amount of proinsulin produced by fermentation of the bacterium was significantly increased to 2.2 g / l. .
机译:本发明涉及一种通过基因工程提高人胰岛素原融合蛋白生产过程中胰岛素原融合蛋白的稳定性和表达率的方法。首先,通过cDNA克隆方法将人胰岛素原基因克隆到大肠杆菌宿主中。将克隆的人类胰岛素原基因与Lac核糖体结合位点基因(Thr)6编码[pUC8-(Thr) 6- PI]和pYK10引入pUC8-(Thr) 6- PI和pEX2。制备了-9表达载体。在大肠杆菌中表达的融合蛋白在大肠杆菌细胞中稳定,其中导入了具有短胰岛素原序列的pYK10-9 Berger。经pYK10-9表达载体转化的大肠杆菌pop2136在烧瓶发酵中产生249 mg / l的人胰岛素原融合蛋白,细菌发酵产生的原胰岛素量显着增加至2.2 g / l。 。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号